Mirae Asset Global Etfs Holdings Ltd. Maxcyte, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Maxcyte, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 62,581 shares of MXCT stock, worth $142,058. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,581
Previous 59,929
4.43%
Holding current value
$142,058
Previous $249,000
31.73%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MXCT
# of Institutions
119Shares Held
73.2MCall Options Held
0Put Options Held
0-
Cadian Capital Management, LP New York, NY10MShares$22.8 Million1.17% of portfolio
-
Black Rock Inc. New York, NY8.14MShares$18.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY7MShares$15.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.57MShares$12.6 Million0.0% of portfolio
-
Vitruvian Partners LLP5.04MShares$11.4 Million13.13% of portfolio
About MAXCYTE, INC.
- Ticker MXCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 101,724,000
- Market Cap $231M
- Description
- MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...